The oxygen-poor regions of solid tumors usually help make them resistant to chemotherapy and other forms of treatment. But researchers at Oregon State University have devised away to take advantage of those hypoxic areas and improve solid tumor treatment with a targeted, liposomal drug delivery system.
The team used the cancer drug, vinblastine, which is a “prodrug” – a pharmacologically inactive compound that the body meatbolizes into an active compound.
Get the full story at our sister site, Drug Delivery Business News.
The post Liposomal drug delivery system could improve solid tumor treatment appeared first on MassDevice.